Bioresource Technology joins Medix Biochemica Group
Publication date : 2022-07-07
We are delighted to announce the acquisition of Bioresource Technology Inc (BRT) – a leading provider of base matrices to the IVD manufacturing industry worldwide, based in Florida.
Further strengthening our US presence, the addition of BRT’s complementary portfolio will mean Medix Biochemica can provide a complete offering of critical raw materials for IVD quality control products. “Together, with our combined portfolios of biological samples, processed plasma, base matrices, native enzymes, proteins, antibodies or antigens, and our depth of expertise, we can dramatically reduce time to market for IVD companies whatever their need. Our vision is to be the first-choice partner for the IVD industry, and the team at BRT takes us one step closer,” says Steve Ferguson, CEO of Medix Biochemica.
Diaclone, Medix Biochemica group: more than 35 years of expertise in Immuno-oncology Publication date : 2023-01-06
Discover how the Diaclone team, and their excellent scientific knowhow can help you in your precious research projects.
Read more
What's New at Diaclone? Publication date : 2022-12-06
A continuous and high-level Research & Development activity to match the needs of our customers and supply the best products...
Read more
For ELISpot choose Diaclone! Publication date : 2022-09-07
Our experience and innovation at your service....
Read more
CE certified product range Publication date : 2022-05-25
Important news concerning our CE Marked product range...
Read more
Support and tools for COVID-19 Research Publication date : 2021-12-17
We provide a wide selection of SARS-CoV-2 antibodies and recombinant proteins to support COVID-19 related assay development.
We are actively working to develop a recombinant SARS-CoV-2 Spike RBD Omicron variant protein and it will be available very soon!
Read more
New! Anti-SARS-CoV-2 RBD domain Neutralizing Antibodies Publication date : 2021-11-03
Our SARS-CoV-2 product range is extended with three anti-RBD (spike protein) "B-" Clones : B-B60, B-D69 and B-R41
Read more
Now available - SARS-CoV-2 Spike RBD Variant Delta Publication date : 2021-07-27
Developed in our laboratories in Besançon (France)
#715-H25-0BU SARS-CoV-2 Spike RBD Variant Delta Lineage B.1.617.2
Read more
Medix Biochemica expands its monoclonal antibody offering through the acquisition of Diaclone Publication date : 2021-07-13
Medix Biochemica has acquired 100 percent of the shares of Diaclone, a prominent provider of monoclonal antibodies in the areas of inflammation, oncology and immunology.
Read more
Diaclone ELISpot assays, tried and trusted by researchers worldwide Publication date : 2021-04-01
Our BEST SELLER the IFNγ ELISpot assay, is widely used in clinical cancer studies and also in COVID-19 research
Read more
ELISpot Kits - A new format to meet your demands Publication date : 2021-02-25
The Diaclone ELISpot kit range is extended with a new 2 PLATE FORMAT
Read more
Monoclonal Antibody Platform Publication date : 2021-02-05
Diaclone and Seed Biosciences collaborate on the development of a new workflow for a faster and more efficient antibody development process
Read more
NEW!... RECOMBINANT HUMAN SARS-CoV-2 PROTEINS Publication date : 2020-10-15
Developed in our laboratories in Besançon (France)
Read more
Anti-S1 Domain Spike Protein is now available at Diaclone Publication date : 2020-08-03
What you need to know about Exosomes Publication date : 2020-07-01
“Huge opportunities”. “Many hurdles”. “Enormous potential”....
Read more
Fast track your Covid-19 Research with Diaclone’s CYTOKINES Publication date : 2020-05-18
Essential tools for Cytokine Storm monitoring & Immunotherapy development...
Read more
Essential tools for COVID-19 and Immunotherapy research Publication date : 2020-04-02
Diaclone provides a large panel of research tools, Monoclonal Antibodies and Immunoassays, for measuring the levels of released cytokines triggered by viral infection (cytokine release syndrome - CRS), including a complete range of human IL-6 and TNF-α products.
Read more
Human IL-6 cytokine, a useful tool for Coronavirus disease (COVID-19) and Immunotherapy research Publication date : 2020-03-20
DIACLONE provides a large panel of products for the quantification of human IL-6 and other human cytokines.
Read more
Discover Diaclone ELISpot Publication date : 2020-02-06
Use Diaclone’s Toolbox to monitor your CAR-T cell responses Publication date : 2019-12-16
In vitro studies with Diaclone’s Toolbox to monitor the risks linked to immunotherapy....
Read more
Diaclone's Toolbox for your Car-T Development Publication date : 2019-11-12
Our Monoclonal Antibodies and ELISpot range are valuable tools for your CAR-T research.
Read more
Use Diaclone’s expertise to further characterize your antibody... Publication date : 2019-10-28
The Octet technology is fully integrated into our custom monoclonal antibody development so that it can be implemented to further study monoclonal antibody candidates.
Read more
CAR-T development Publication date : 2019-10-01
How can Diaclone support your CAR-T development?
Read more
DIACLONE Assays for the Human IL-17 Family Publication date : 2019-08-28
Diaclone has developed a large range of ELISA and ELISpot kits for the detection of Human IL-17A, IL-17F and IL-17A/F.
Read more
The CAM family: A new target for monitoring or treating cancers? Publication date : 2019-08-28
The cell adhesion molecules (CAMs) family includes more than 50 proteins with four main groups: immunoglobulin (Ig)-like CAMs, cadherins, selectins, and integrins.
Read more
